Literature DB >> 25117709

Tumor vessel normalization by chloroquine independent of autophagy.

Hannelore Maes1, Anna Kuchnio2, Aleksandar Peric3, Stijn Moens2, Kris Nys1, Katrien De Bock2, Annelies Quaegebeur2, Sandra Schoors2, Maria Georgiadou2, Jasper Wouters4, Stefan Vinckier2, Hugo Vankelecom5, Marjan Garmyn6, Anne-Clémence Vion7, Freddy Radtke8, Chantal Boulanger7, Holger Gerhardt9, Elisabetta Dejana10, Mieke Dewerchin2, Bart Ghesquière2, Wim Annaert3, Patrizia Agostinis11, Peter Carmeliet2.   

Abstract

Chloroquine (CQ) has been evaluated as an autophagy blocker for cancer treatment, but it is unknown if it acts solely by inhibiting cancer cell autophagy. We report that CQ reduced tumor growth but improved the tumor milieu. By normalizing tumor vessel structure and function and increasing perfusion, CQ reduced hypoxia, cancer cell invasion, and metastasis, while improving chemotherapy delivery and response. Inhibiting autophagy in cancer cells or endothelial cells (ECs) failed to induce such effects. CQ's vessel normalization activity relied mainly on alterations of endosomal Notch1 trafficking and signaling in ECs and was abrogated by Notch1 deletion in ECs in vivo. Thus, autophagy-independent vessel normalization by CQ restrains tumor invasion and metastasis while improving chemotherapy, supporting the use of CQ for anticancer treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117709     DOI: 10.1016/j.ccr.2014.06.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  149 in total

Review 1.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

2.  Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.

Authors:  Sandy Giuliano; Yann Cormerais; Maeva Dufies; Renaud Grépin; Pascal Colosetti; Amine Belaid; Julien Parola; Anthony Martin; Sandra Lacas-Gervais; Nathalie M Mazure; Rachid Benhida; Patrick Auberger; Baharia Mograbi; Gilles Pagès
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

3.  Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1.

Authors:  Michael B Lazarus; Kevan M Shokat
Journal:  Bioorg Med Chem       Date:  2015-07-26       Impact factor: 3.641

Review 4.  Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.

Authors:  John D Martin; Giorgio Seano; Rakesh K Jain
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

Review 5.  Molecular definitions of autophagy and related processes.

Authors:  Lorenzo Galluzzi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Francesco Cecconi; Augustine M Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Jayanta Debnath; Vojo Deretic; Ivan Dikic; Eeva-Liisa Eskelinen; Gian Maria Fimia; Simone Fulda; David A Gewirtz; Douglas R Green; Malene Hansen; J Wade Harper; Marja Jäättelä; Terje Johansen; Gabor Juhasz; Alec C Kimmelman; Claudine Kraft; Nicholas T Ktistakis; Sharad Kumar; Beth Levine; Carlos Lopez-Otin; Frank Madeo; Sascha Martens; Jennifer Martinez; Alicia Melendez; Noboru Mizushima; Christian Münz; Leon O Murphy; Josef M Penninger; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Laura Santambrogio; Luca Scorrano; Anna Katharina Simon; Hans-Uwe Simon; Anne Simonsen; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Guido Kroemer
Journal:  EMBO J       Date:  2017-06-08       Impact factor: 11.598

Review 6.  Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Sandra Demaria; Silvia Chiara Formenti; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2016-11-15       Impact factor: 66.675

Review 7.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

8.  Vaccine therapy + dasatinib for the treatment of patients with stage IIIB-IV melanoma.

Authors:  Ahmad A Tarhini; Hussein Tawbi; Walter J Storkus
Journal:  Melanoma Manag       Date:  2016-11-29

9.  An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells.

Authors:  Shaun Martin; Aleksandra M Dudek-Peric; Abhishek D Garg; Heleen Roose; Seyma Demirsoy; Sofie Van Eygen; Freya Mertens; Peter Vangheluwe; Hugo Vankelecom; Patrizia Agostinis
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

Review 10.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.